The Effects of IL-20 Subfamily Cytokines on Reconstituted Human Epidermis Suggest Potential Roles in Cutaneous Innate Defense and Pathogenic Adaptive Immunity in Psoriasis
暂无分享,去创建一个
S. Sa | P. Valdez | Jianfeng Wu | K. Jung | F. Zhong | L. Hall | I. Kasman | J. Winer | Z. Modrušan | D. Danilenko | W. Ouyang | Z. Modrusan
[1] B. Nickoloff,et al. The cytokine network in psoriasis. , 1991, Archives of dermatology.
[2] M. Yamamura,et al. The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response. , 1993, The Journal of investigative dermatology.
[3] O. Mcbride,et al. Human trichohyalin gene is clustered with the genes for other epidermal structural proteins and calcium-binding proteins at chromosomal locus 1q21. , 1993, The Journal of investigative dermatology.
[4] J. Darnell,et al. Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. , 1994, Science.
[5] W. Jochum,et al. T cells involved in psoriasis vulgaris belong to the Th1 subset. , 1994, The Journal of investigative dermatology.
[6] M. Manabe,et al. Existence of trichohyalin-keratohyalin hybrid granules: co-localization of two major intermediate filament-associated proteins in non-follicular epithelia. , 1994, Differentiation; research in biological diversity.
[7] Z. Su,et al. Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression. , 1995, Oncogene.
[8] B. Honoré,et al. Psoriasin: a novel chemotactic protein. , 1996, The Journal of investigative dermatology.
[9] M. Piepkorn,et al. Overexpression of amphiregulin, a major autocrine growth factor for cultured human keratinocytes, in hyperproliferative skin diseases. , 1996, The American Journal of dermatopathology.
[10] J. Darnell. STATs and gene regulation. , 1997, Science.
[11] Y. Hashimoto,et al. Distinctive expression of filaggrin and trichohyalin during various pathways of epithelial differentiation , 1997, The British journal of dermatology.
[12] J. Brown,et al. Transgenic expression of the human amphiregulin gene induces a psoriasis-like phenotype. , 1997, The Journal of clinical investigation.
[13] M. Pittelkow,et al. Autocrine regulation of keratinocytes: the emerging role of heparin-binding, epidermal growth factor-related growth factors. , 1998, The Journal of investigative dermatology.
[14] M. Longaker,et al. Cutaneous rat wounds express C49a, a novel gene with homology to the human melanoma differentiation associated gene, Mda‐7 , 1999, Journal of cellular biochemistry.
[15] M. Pittelkow,et al. Overexpression of amphiregulin in the epidermis of transgenic mice induces a psoriasis-like cutaneous phenotype. , 1999, The Journal of investigative dermatology.
[16] T. Kupper,et al. Interleukin-1 and cutaneous inflammation: a crucial link between innate and acquired immunity. , 2000, The Journal of investigative dermatology.
[17] Zemin Zhang,et al. Interleukin (IL)-22, a Novel Human Cytokine That Signals through the Interferon Receptor-related Proteins CRF2–4 and IL-22R* , 2000, The Journal of Biological Chemistry.
[18] A. Gurney,et al. Acinar cells of the pancreas are a target of interleukin-22. , 2001, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[19] A. Bowcock,et al. Insights into psoriasis and other inflammatory diseases from large-scale gene expression studies. , 2001, Human molecular genetics.
[20] D. Lejeune,et al. Cutting Edge: STAT Activation By IL-19, IL-20 and mda-7 Through IL-20 Receptor Complexes of Two Types1 , 2001, The Journal of Immunology.
[21] J G Krueger,et al. Molecular classification of psoriasis disease-associated genes through pharmacogenomic expression profiling , 2001, The Pharmacogenomics Journal.
[22] D. Conklin,et al. Interleukin 20 Discovery, Receptor Identification, and Role in Epidermal Function , 2001, Cell.
[23] S. Pestka,et al. Identification of the Functional Interleukin-22 (IL-22) Receptor Complex , 2001, The Journal of Biological Chemistry.
[24] A. Sahin,et al. Down‐regulated melanoma differentiation associated gene (mda‐7) expression in human melanomas , 2001, International journal of cancer.
[25] A D Long,et al. Improved Statistical Inference from DNA Microarray Data Using Analysis of Variance and A Bayesian Statistical Framework , 2001, The Journal of Biological Chemistry.
[26] K. Madden,et al. Interleukins 19, 20, and 24 Signal through Two Distinct Receptor Complexes , 2002, The Journal of Biological Chemistry.
[27] S. Kotenko,et al. Interleukin 24 (MDA-7/MOB-5) Signals through Two Heterodimeric Receptors, IL-22R1/IL-20R2 and IL-20R1/IL-20R2* , 2002, The Journal of Biological Chemistry.
[28] S. Kotenko,et al. Interleukin 24 ( MDA-7 / MOB-5 ) Signals through Two Heterodimeric Receptors , IL-22 R 1 / IL-20 R 2 and IL-20 R 1 / IL-20 R 2 * , 2002 .
[29] K. Asadullah,et al. Cutting Edge: Immune Cells as Sources and Targets of the IL-10 Family Members? , 2002, The Journal of Immunology.
[30] Selective enhancement of multipotential hematopoietic progenitors in vitro and in vivo by IL-20. , 2003, Blood.
[31] J. Renauld. Class II cytokine receptors and their ligands: Key antiviral and inflammatory modulators , 2003, Nature Reviews Immunology.
[32] K. Kragballe,et al. Epidermal overexpression of interleukin-19 and -20 mRNA in psoriatic skin disappears after short-term treatment with cyclosporine a or calcipotriol. , 2003, The Journal of investigative dermatology.
[33] K. Kristiansen,et al. Expression and localization of peroxisome proliferator-activated receptors and nuclear factor kappaB in normal and lesional psoriatic skin. , 2003, The Journal of investigative dermatology.
[34] M. Blumenberg,et al. Unique Keratinocyte-Specific Effects of Interferon-γ that Protect Skin from Viruses, Identified Using Transcriptional Profiling , 2002, Antiviral therapy.
[35] John D. Storey,et al. Statistical significance for genomewide studies , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[36] R. Underwood,et al. Proliferation–differentiation relationships in the expression of heparin-binding epidermal growth factor-related factors and erbB receptors by normal and psoriatic human keratinocytes , 2003, Archives of Dermatological Research.
[37] Wing Hung Wong,et al. Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63,100-element oligonucleotide array. , 2003, Physiological genomics.
[38] T. Kupper,et al. Immune surveillance in the skin: mechanisms and clinical consequences , 2004, Nature Reviews Immunology.
[39] A. Zdanov. Structural features of the interleukin-10 family of cytokines. , 2004, Current pharmaceutical design.
[40] Kathleen C. Lee,et al. S100 proteins in the epidermis. , 2004, The Journal of investigative dermatology.
[41] F. Nestle,et al. Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities. , 2004, The Journal of clinical investigation.
[42] M. Pittelkow,et al. Suprabasal expression of human amphiregulin in the epidermis of transgenic mice induces a severe, early‐onset, psoriasis‐like skin pathology: Expression of amphiregulin in the basal epidermis is also associated with synovitis , 2004, Experimental dermatology.
[43] A. Gottlieb,et al. A phase I study evaluating the safety, pharmacokinetics, and clinical response of a human IL-12 p40 antibody in subjects with plaque psoriasis. , 2004, The Journal of investigative dermatology.
[44] M. Dhodapkar,et al. Increased Expression of Interleukin 23 p19 and p40 in Lesional Skin of Patients with Psoriasis Vulgaris , 2004, The Journal of experimental medicine.
[45] G. Church,et al. Preferred analysis methods for Affymetrix GeneChips revealed by a wholly defined control dataset , 2005, Genome Biology.
[46] T. Mcclanahan,et al. Expression patterns of IL-10 ligand and receptor gene families provide leads for biological characterization. , 2004, International immunopharmacology.
[47] M. Simon,et al. Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family, SCTE/KLK5/hK5 and SCCE/KLK7/hK7. , 2004, The Journal of investigative dermatology.
[48] K. Asadullah,et al. IL-22 increases the innate immunity of tissues. , 2004, Immunity.
[49] S. Kotenko,et al. Full house: 12 receptors for 27 cytokines. , 2004, International immunopharmacology.
[50] S. Smirnov,et al. Cutting Edge: IL-26 Signals through a Novel Receptor Complex Composed of IL-20 Receptor 1 and IL-10 Receptor 2 1 , 2004, The Journal of Immunology.
[51] J. Renauld,et al. The T-cell Lymphokine Interleukin-26 Targets Epithelial Cells through the Interleukin-20 Receptor 1 and Interleukin-10 Receptor 2 Chains* , 2004, Journal of Biological Chemistry.
[52] A. Bowcock,et al. Psoriasis vulgaris: cutaneous lymphoid tissue supports T-cell activation and "Type 1" inflammatory gene expression. , 2004, Trends in immunology.
[53] M. Blumenberg,et al. Effects of Tumor Necrosis Factor-α (TNFα) in Epidermal Keratinocytes Revealed Using Global Transcriptional Profiling* , 2004, Journal of Biological Chemistry.
[54] C. D. Krause,et al. Interleukin-10 and related cytokines and receptors. , 2004, Annual review of immunology.
[55] E. Diamandis,et al. Multiple tissue kallikrein mRNA and protein expression in normal skin and skin diseases , 2005, The British journal of dermatology.
[56] K. Hiromura,et al. Expression of interleukin-22 in rheumatoid arthritis: potential role as a proinflammatory cytokine. , 2005, Arthritis and rheumatism.
[57] J. Schröder,et al. Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection , 2005, Nature Immunology.
[58] R. Pfundt,et al. High expression levels of keratinocyte antimicrobial proteins in psoriasis compared with atopic dermatitis. , 2005, The Journal of investigative dermatology.
[59] A. Bowcock,et al. Getting under the skin: the immunogenetics of psoriasis , 2005, Nature Reviews Immunology.
[60] James Varani,et al. Amphiregulin and epidermal hyperplasia: amphiregulin is required to maintain the psoriatic phenotype of human skin grafts on severe combined immunodeficient mice. , 2005, The American journal of pathology.
[61] A. Gurney,et al. IL-22 Inhibits Epidermal Differentiation and Induces Proinflammatory Gene Expression and Migration of Human Keratinocytes1 , 2005, The Journal of Immunology.
[62] A. Takayanagi,et al. Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts. , 2005, Gastroenterology.
[63] J. Clausen,et al. The dynamics of gene expression of interleukin‐19 and interleukin‐20 and their receptors in psoriasis , 2005, The British journal of dermatology.
[64] W‐C. Chen,et al. Interleukin‐19 upregulates keratinocyte growth factor and is associated with psoriasis , 2005, The British journal of dermatology.
[65] M. Boniotto,et al. Human IL‐19 regulates immunity through auto‐induction of IL‐19 and production of IL‐10 , 2005, European journal of immunology.
[66] J. Clifford,et al. Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model , 2005, Nature Medicine.
[67] M. Brattsand,et al. A proteolytic cascade of kallikreins in the stratum corneum. , 2005, The Journal of investigative dermatology.
[68] Ming-Shi Chang,et al. Detection of IL-20 and its receptors on psoriatic skin. , 2005, Clinical immunology.
[69] K. Herrmann,et al. IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration. , 2006, American journal of physiology. Gastrointestinal and liver physiology.
[70] J. Krueger,et al. Prominent production of IL-20 by CD68+/CD11c+ myeloid-derived cells in psoriasis: Gene regulation and cellular effects. , 2006, The Journal of investigative dermatology.
[71] K. Asadullah,et al. IL‐22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis , 2006, European journal of immunology.
[72] Y. Iwakura,et al. The IL-23/IL-17 axis in inflammation. , 2006, The Journal of clinical investigation.
[73] P. Valdez,et al. Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis , 2007, Nature.
[74] D. Greenhalgh,et al. Cutaneous Wound Healing , 2007, Journal of burn care & research : official publication of the American Burn Association.